ISRCTN26840121已完成1 期
A drug-drug interaction study of the effect of DNL343 on midazolam pharmacokinetics in healthy participants
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 16
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Healthy female participants of non-childbearing potential or healthy male participants between 18 and 65 years of age, inclusive
- •2. Body mass index (BMI) between 18.5 and 30 kg/m² and a body weight of at least 50 kg
排除标准
- •1. Any history of hepatic, pulmonary, and/or renal disease
- •2. History of serious adverse reaction or serious hypersensitivity to any drug
- •3. History of allergy to any component of the study intervention
- •4. Have any surgical or medical condition affecting drug absorption (eg, gastrectomy)
研究者
相似试验
已完成
1 期
A drug interaction study of DUR-928 and Midozolamiver DiseaseACTRN12617000579392INC Research18
撤回
4 期
Study on the pharmacokinetic interaction between diclofenac and tamoxifen in patients with breast cancer. the DICLOTAM studyNL-OMON48096Erasmus MC, Universitair Medisch Centrum Rotterdam14
已完成
不适用
A drug-drug interaction study between the novel anti-HCV agent DAclatasvir and The antidiabetic agent mEtformine in healthy volunteers.HCV1001842410047438diabetes mellitusHepatitis CNL-OMON42748Apotheek20
已完成
不适用
A drug-drug interaction study between the novel anti-HCV agent daclatasvir and the antiretroviral agents atazanavir/ritonavir or atazanavir/cobicistat in healthy volunteers.HCVHIV10047438Hepatitis CNL-OMON42827Apotheek16
进行中（未招募）
不适用
Study on the pharmacodynamic interactions between propofol and sevoflurane during induction of anesthesia.AnesthesiaEUCTR2005-004632-40-BEniversity Hospital Ghent60